0001209191-18-036127.txt : 20180606 0001209191-18-036127.hdr.sgml : 20180606 20180606172805 ACCESSION NUMBER: 0001209191-18-036127 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180604 FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirson Eilon D. CENTRAL INDEX KEY: 0001654356 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 18884607 MAIL ADDRESS: STREET 1: TOPAZ BUILDING, MATAN CENTER CITY: HAIFA STATE: L3 ZIP: 31905 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-04 0 0001645113 NovoCure Ltd NVCR 0001654356 Kirson Eilon D. C/O NOVOCURE INC., VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Science Officer Ordinary Shares 2018-06-04 4 M 0 218781 7.03 A 258363 D Ordinary Shares 2018-06-04 4 S 0 225296 28.60 D 33067 D Ordinary Shares 2018-06-04 4 M 0 59130 7.48 A 92197 D Ordinary Shares 2018-06-04 4 M 0 68250 7.15 A 160447 D Ordinary Shares 2018-06-04 4 S 0 114934 29.36 D 45513 D Ordinary Shares 2018-06-04 4 S 0 1800 30.26 D 43713 D Ordinary Shares 2018-06-04 4 S 0 4131 31.74 D 39582 D Options to Buy Ordinary Shares 7.03 2018-06-04 4 M 0 218781 0.00 A 2023-02-19 Ordinary Shares 218781 0 D Options to Buy Ordinary Shares 7.48 2018-06-04 4 M 0 59130 0.00 A 2024-02-25 Ordinary Shares 59130 0 D Options to Buy Ordinary Shares 7.15 2018-06-04 4 M 0 68250 0.00 A 2027-02-21 Ordinary Shares 68250 204750 D On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 225,296 shares in multiple trades at prices ranging from $28.00 to $28.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 114,934 shares in multiple trades at prices ranging from $29.00 to $29.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 1,800 shares in multiple trades at prices ranging from $30.00 to $30.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On June 4, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 4,131 shares in multiple trades at prices ranging from $31.00 to $31.99. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Options exercised were fully vested as of the date hereof. By: /s/ Kimberly Burke, Attorney in fact for Eilon D. Kirson 2018-06-06